Association between 25-hydroxy vitamin D levels, physical activity, muscle strength and fractures in the prospective population-based OPRA Study of Elderly Women.
Vitamin D supplements have been used to prevent fractures. The effect may be mediated through increased bone mass, but also through reduced falling propensity. The aim of this study was to evaluate the association between 25-hydroxy vitamin D levels (25OHD), fall-associated variables (including tests of functional performance), and fracture in ambulatory women. At baseline 25OHD was measured in 986 women. Fall-associated variables were investigated at baseline. Fractures were recorded during a 3-year follow-up. Four percent of the women had 25OHD levels below 20 ng/ml (50 nmol/l), and 26% had 25OHD levels below 30 ng/ml (75 nmol/l). 25OHD correlated with gait speed (r =0.17, P <0.001), the Romberg balance test (r =0.14, P <0.001), self-estimated activity level (r =0.15, P <0.001), and thigh muscle strength (r =0.08, P =0.02). During the 3-year follow-up, 119 out of the 986 women sustained at least one fracture. The Cox proportional hazard ratio (HR) (95% confidence interval) for sustaining a fracture during the follow-up was 2.04 (1.04-4.04) for the group of women with 25OHD below 20 ng/ml, in which 9 out of 43 women sustained a fracture. Thirty-two of the 256 women with 25OHD levels below 30 ng/ml sustained a fracture during the follow-up, with a non-significant HR of 1.07 (1.07-1.61). This cohort of elderly, ambulatory women had a high mean 25OHD. A low 25OHD was associated with inferior physical activity level, gait speed and balance. A 25OHD level below 30 ng/ml was not associated with an increased risk of fractures in this study. However, a subgroup of women with 25OHD levels below 20 ng/ml had a tendency to an increased risk of fractures, which may be associated with an inferior physical activity and postural stability.
Gerdhem
P
P
Department of Orthopedics, Malmö University Hospital, Lund University, Malmö, Sweden. paul.gerdhem@skane.se
Ringsberg
K A M
KA
Obrant
K J
KJ
Akesson
K
K
D000058:Accidental Falls; D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density; D002112:Calcifediol / Q000097:blood*; D015331:Cohort Studies; D005260:Female; D050723:Fractures, Bone / Q000453:epidemiology*; D006801:Humans; D009043:Motor Activity; D018482:Muscle, Skeletal / Q000502:physiology*; D011237:Predictive Value of Tests; D012307:Risk Factors; D013548:Sweden / Q000453:epidemiology; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000097:blood
D014807:Vitamin D; C104450:25-hydroxyvitamin D; D002112:Calcifediol
Age Ageing. 1985 Mar;14(2):76-84
4003187
Cochrane Database Syst Rev. 2001;(1):CD000227
11279685
Osteoporos Int. 2003 May;14(3):208-12
12730785
Endocr Rev. 2001 Aug;22(4):477-501
11493580
Osteoporos Int. 1995;5(4):239-46
7492862
J Am Geriatr Soc. 1999 Oct;47(10):1195-201
10522952
J Bone Miner Res. 2002 May;17(5):891-7
12009020
Lancet. 2002 Jun 1;359(9321):1929-36
12057569
Arch Phys Med Rehabil. 1999 Jan;80(1):54-8
9915372
J Bone Miner Res. 2000 Jun;15(6):1113-8
10841179
Calcif Tissue Int. 2000 Jun;66(6):419-24
10821877
Aging (Milano). 1999 Jun;11(3):200-7
10476316
Am J Clin Nutr. 2003 Feb;77(2):504-11
12540414
Osteoporos Int. 2002 Mar;13(3):187-94
11991436
J Bone Miner Res. 2003 Feb;18(2):343-51
12568412
Osteoporos Int. 1999;9(5):394-7
10550457
J Am Geriatr Soc. 1999 Feb;47(2):220-6
9988294
Lancet. 1998 Mar 14;351(9105):805-6
9519960
Cochrane Database Syst Rev. 2003;(4):CD000340
14583918
Gerontology. 2003 Mar-Apr;49(2):93-116
12574670
Clin Lab. 2001;47(7-8):357-65
11499797
J Am Coll Nutr. 2003 Apr;22(2):142-6
12672710
Lancet. 1976 Mar 20;1(7960):626-9
55903
J Clin Endocrinol Metab. 2004 Jul;89(7):3152-7
15240586
N Engl J Med. 1997 Sep 4;337(10):670-6
9278463
N Engl J Med. 1995 Mar 23;332(12):767-73
7862179
J Am Geriatr Soc. 1995 Nov;43(11):1269-71
7594162
Am J Med. 1992 Jul;93(1):69-77
1385673
J Bone Miner Res. 1988 Aug;3(4):369-73
3265576
Gerontology. 2003 May-Jun;49(3):168-72
12679607
N Engl J Med. 1998 Sep 10;339(11):733-8
9731089
Age Ageing. 1999 May;28(3):289-93
10475866
J Clin Endocrinol Metab. 2004 Jul;89(7):3149-51
15240585
Osteoporos Int. 1997;7(5):439-43
9425501
BMJ. 2003 Mar 1;326(7387):469
12609940
Osteoporos Int. 2003 Apr;14 (2):152-9
12730772
J Clin Endocrinol Metab. 1988 May;66(5):927-33
3360900
JAMA. 2004 Apr 28;291(16):1999-2006
15113819